People

The People Running Niu

Figures converted from Chinese yuan (CNY) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Governance grade: C. A small, professionalised executive team sits inside a control architecture engineered for insiders: dual-class shares, a 38% stake parked in an opaque Cayman trust, a co-founder who left the board but kept 17% of the vote, and a board that has not changed since the 2018 IPO. Nothing in the disclosures suggests fraud — but the machinery is clearly built to entrench, not to be challenged.

The People Running This Company

Five directors, two of them inside (Yan Li and Fion Zhou). Bench depth beyond those two is invisible in the disclosures — Niu does not name a COO, CTO, or head of operations as a separately reported officer. That makes Yan Li, who simultaneously chairs the board, runs the company, and is the largest individual economic owner, a single point of failure.

What matters in those bios. Yan Li is the credibility anchor: a Stanford EE PhD with a real operating track record at KKR Capstone where he ran portfolio operations across Haier, China Modern Dairy, China Cord Blood and United Envirotech. Fion Zhou is the rare CFO who has actually closed books at three NYSE/NASDAQ filers (Sogou, Concord Medical, Niu) and survived a stint inside Alibaba's finance org — she is the strongest hire of the last five years. The three independents are credentialed but old-guard: all three joined the day Niu IPO'd in October 2018 and none have rotated off in nearly eight years.

What They Get Paid

Niu is a foreign private issuer and discloses compensation only in aggregate. The cash bill is trivial; the equity grant story is not.

Reading the numbers. The cash bill — $0.72M total for the entire C-suite plus all directors — is genuinely modest for a Nasdaq-listed manufacturer with $603M of revenue and 671 employees. The story is in the equity. Yan Li's 1.5M-share RSU grant on January 10, 2025 was awarded after three consecutive loss years (FY22, FY23, FY24) and was struck at the depressed $1.71 ADS price, locking in roughly $2.6M of value before any subsequent appreciation. Fion Zhou's 300,000-share grant on the same day adds another $0.5M. The board took a similar gift on October 19, 2024: 40,000 RSUs each to the three "independent" directors at $1.84. None of these grants are individually outrageous, but they were all structured to maximise reward when the stock was near multi-year lows — without any disclosed performance vesting hurdle. The Amended 2018 Plan also has an evergreen reload of 1.5% of issued shares per year, a structural drag rarely seen at companies this small.

Are They Aligned?

This is the section that decides the tab. Niu has insider ownership and even meaningful voting power, but the architecture turns "alignment" into "control over outsiders." Three Class B holders together carry ~47% of the vote on just 9.7% of the economics.

The Bull Trust wrinkle. Glory Achievement Fund, holder of 38.4% of the economics, did not appear on the cap table until December 2023. Since then it has filed seven Schedule 13D/A amendments in the last twelve months — five of them in the first ten weeks of 2026 alone (Feb 2, Feb 11, Mar 4, Mar 13, plus a July 2025 amendment). The disclosure states that voting and disposal decisions sit with "three individual protectors unrelated to Mr. Li" until August 2028 (or until the trust drops below 10%). For outside shareholders this is the worst of both worlds: a 30% voting block with high recent turnover whose disposal trigger is invisible to the market, controlled by a fiduciary structure whose protectors cannot be removed by the beneficiary for two more years.

Skin in the game. Yan Li's combined direct stake — 1.5M Class A plus 6.6M Class B via ELLY Holdings BVI, ~5.2% of the economics — is real personal exposure for a 47-year-old CEO. He has not exercised his 930,000 underwater options struck at $3.425 against an ADS price now under half that. There is no disclosed promoter pledge, no margin loan, no obvious related-party trading on his own account. That is the alignment positive. The alignment negative is that his direct economic ownership is dwarfed by the Glory Achievement Fund position whose intentions outside shareholders cannot read.

Dilution. Modest at the absolute level — ordinary shares grew from 152.4M (end FY2020) to 156.9M (Feb 2026), under 1% a year. The 2018 Plan's 1.5% evergreen would imply faster dilution but actual usage has been slower because the share price has stayed under water. Stock-based compensation has fallen from $8.4M in FY22 to $4.0M in FY25 alongside the share price.

Related-party. The 20-F directs readers to the VIE contractual arrangements — the standard Cayman-holdco / WFOE / China-OpCo VIE structure that every NYSE/NASDAQ-listed Chinese company carries. There is no disclosed director self-dealing, no related-party customer or supplier transaction at scale. The VIE risk is the structural risk every Chinese ADR has, not a specific Niu pathology.

Score = 5/10. Yan Li's direct equity stake of ~$18M is meaningful and unencumbered. The drag is the dual-class lock-up plus the opaque ~30%-voting Bull Trust position, both of which weaken the practical link between management decisions and outside-shareholder outcomes.

Board Quality

Five seats, three "independent" by Nasdaq Rule 5605. All three independents joined at IPO in October 2018, all three are over 55, and one chairs an audit committee while sitting on five other Asia-listed public boards. There is no minority-shareholder-elected director, no separate lead independent director, and the company qualifies for foreign-private-issuer exemptions from many Nasdaq governance standards.

The Verdict

Grade: C. This is a competently run company sitting inside a control architecture designed for insiders. The CEO is credible and committed economically, the CFO is a strong recent hire, the cash bill is modest, the audit committee box is properly ticked, and there is no specific disclosed scandal, pledge, or self-dealing.

The real concerns are structural, not behavioural. A ~47% voting block sits in three offshore vehicles — one of which (Glory Achievement Fund / Bull Trust) only appeared on the cap table two years ago and has filed seven 13D amendments in the last twelve months. The co-founder is gone but still controls 17% of the vote. The three independent directors have not rotated in nearly eight years; the audit committee chair sits on five other Asian listed boards. Together these mean outside shareholders carry the economic risk of a money-losing business through cycles, but cannot expect a board vote or a friendly tender to ever change the outcome.

What would upgrade it to B: rotation of at least one independent director (especially Ye, removing the overboarding), separation of CEO and Chair (or appointment of a lead independent director), and either retirement of Class B voting differential or a sunset on it. Glory Achievement Fund clarifying its long-term intentions and ending the 13D churn would also help.

What would downgrade it to D: any pledge, margin financing, or related-party transaction emerging from the Bull Trust; a sudden related-party customer or supplier deal; a delisting threat under HFCAA; or an unexpected resignation by Fion Zhou, who is currently the strongest non-CEO voice in the room.